These results suggest that ASPN+ FIBs are responding to an inflamed microenvironment in BCC and that rewiring of the stroma could arise from inflammatory signals, possibly due to cross-talk with immune cells that have invaded the dermis during BCC progression. The gene discussed is ASPN; the disease is skin basal cell carcinoma.